(ANA) Acciona - Overview
Stock: Renewable Energy, Infrastructure, Water Treatment, Construction, Real Estate
| Risk 5d forecast | |
|---|---|
| Volatility | 28.1% |
| Relative Tail Risk | 3.78% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.02 |
| Alpha | 68.96 |
| Character TTM | |
|---|---|
| Beta | 0.529 |
| Beta Downside | 0.370 |
| Drawdowns 3y | |
|---|---|
| Max DD | 45.58% |
| CAGR/Max DD | 0.17 |
Description: ANA Acciona February 18, 2026
Acciona S.A. (ticker ANA) is a diversified Spanish group that operates across three core pillars: renewable energy generation (wind, solar PV, solar thermal, hydro, biomass and storage), large-scale infrastructure (transport, water, data-center and energy-grid assets), and a portfolio of “smart-city” services that includes water treatment, healthcare, tourism facilities, and financial asset management. The company’s business model spans project development, construction, operation and long-term maintenance, giving it exposure to both capital-intensive build-out cycles and recurring service revenues.
According to Acciona’s 2024 annual report, the group generated €10.2 billion of revenue, with the Renewable Energy segment contributing €4.6 billion (≈45 % of total) and reporting an adjusted EBITDA margin of 7.5 %. As of 31 December 2024, Acciona owned roughly 12 GW of renewable capacity worldwide and had an order backlog of €4.1 billion, of which €2.3 billion relates to new wind-farm contracts in Europe and Latin America. The Infrastructure division posted a 4.2 % EBITDA margin, driven by a €1.8 billion pipeline of highway and rail concessions secured under Spain’s 2025-2027 public-works plan.
Key macro drivers underpinning Acciona’s outlook include the EU Green Deal’s target of 40 % renewable electricity by 2030, which is expected to channel €1 trillion of public and private investment into clean-energy projects, and Spain’s National Infrastructure Strategy that earmarks €30 billion for transport and water-resource upgrades through 2028. Both trends should sustain demand for Acciona’s integrated design-build-operate capabilities, though execution risk remains high in jurisdictions with volatile regulatory frameworks.
For a deeper quantitative assessment, see the Acciona profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 832.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 3.70 > 1.0 |
| NWC/Revenue: 7.21% < 20% (prev 4.65%; Δ 2.56% < -1%) |
| CFO/TA 0.07 > 3% & CFO 2.52b > Net Income 832.0m |
| Net Debt (8.77b) to EBITDA (2.38b): 3.68 < 3 |
| Current Ratio: 1.12 > 1.5 & < 3 |
| Outstanding Shares: last quarter (54.5m) vs 12m ago -0.12% < -2% |
| Gross Margin: 67.60% > 18% (prev 0.68%; Δ 6692 % > 0.5%) |
| Asset Turnover: 64.62% > 50% (prev 60.65%; Δ 3.97% > 0%) |
| Interest Coverage Ratio: 2.33 > 6 (EBITDA TTM 2.38b / Interest Expense TTM 667.0m) |
Altman Z'' 1.14
| A: 0.05 (Total Current Assets 14.66b - Total Current Liabilities 13.10b) / Total Assets 34.41b |
| B: 0.11 (Retained Earnings 3.92b / Total Assets 34.41b) |
| C: 0.05 (EBIT TTM 1.56b / Avg Total Assets 33.56b) |
| D: 0.16 (Book Value of Equity 4.42b / Total Liabilities 28.37b) |
| Altman-Z'' Score: 1.14 = BB |
Beneish M -3.15
| DSRI: 0.84 (Receivables 4.51b/4.94b, Revenue 21.69b/19.84b) |
| GMI: 1.01 (GM 67.60% / 68.05%) |
| AQI: 0.99 (AQ_t 0.28 / AQ_t-1 0.29) |
| SGI: 1.09 (Revenue 21.69b / 19.84b) |
| TATA: -0.05 (NI 832.0m - CFO 2.52b) / TA 34.41b) |
| Beneish M-Score: -3.15 (Cap -4..+1) = AA |
What is the price of ANA shares?
Over the past week, the price has changed by +0.36%, over one month by +8.88%, over three months by +15.56% and over the past year by +80.41%.
Is ANA a buy, sell or hold?
What are the forecasts/targets for the ANA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 174.9 | -11.5% |
| Analysts Target Price | - | - |
ANA Fundamental Data Overview February 22, 2026
P/E Trailing = 12.9339
P/E Forward = 21.3675
P/S = 0.4963
P/B = 2.3225
Revenue TTM = 21.69b EUR
EBIT TTM = 1.56b EUR
EBITDA TTM = 2.38b EUR
Long Term Debt = 10.11b EUR (from longTermDebt, last quarter)
Short Term Debt = 2.53b EUR (from shortTermDebt, last quarter)
Debt = 13.24b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.77b EUR (from netDebt column, last quarter)
Enterprise Value = 19.17b EUR (10.76b + Debt 13.24b - CCE 4.84b)
Interest Coverage Ratio = 2.33 (Ebit TTM 1.56b / Interest Expense TTM 667.0m)
EV/FCF = 85.57x (Enterprise Value 19.17b / FCF TTM 224.0m)
FCF Yield = 1.17% (FCF TTM 224.0m / Enterprise Value 19.17b)
FCF Margin = 1.03% (FCF TTM 224.0m / Revenue TTM 21.69b)
Net Margin = 3.84% (Net Income TTM 832.0m / Revenue TTM 21.69b)
Gross Margin = 67.60% ((Revenue TTM 21.69b - Cost of Revenue TTM 7.03b) / Revenue TTM)
Gross Margin QoQ = 70.51% (prev 70.51%)
Tobins Q-Ratio = 0.56 (Enterprise Value 19.17b / Total Assets 34.41b)
Interest Expense / Debt = 0.92% (Interest Expense 121.5m / Debt 13.24b)
Taxrate = 6.85% (24.5m / 357.5m)
NOPAT = 1.45b (EBIT 1.56b * (1 - 6.85%))
Current Ratio = 1.12 (Total Current Assets 14.66b / Total Current Liabilities 13.10b)
Debt / Equity = 2.91 (Debt 13.24b / totalStockholderEquity, last quarter 4.55b)
Debt / EBITDA = 3.68 (Net Debt 8.77b / EBITDA 2.38b)
Debt / FCF = 39.14 (Net Debt 8.77b / FCF TTM 224.0m)
Total Stockholder Equity = 4.68b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.48% (Net Income 832.0m / Total Assets 34.41b)
RoE = 17.78% (Net Income TTM 832.0m / Total Stockholder Equity 4.68b)
RoCE = 10.53% (EBIT 1.56b / Capital Employed (Equity 4.68b + L.T.Debt 10.11b))
RoIC = 8.66% (NOPAT 1.45b / Invested Capital 16.75b)
WACC = 3.34% (E(10.76b)/V(24.01b) * Re(6.39%) + D(13.24b)/V(24.01b) * Rd(0.92%) * (1-Tc(0.07)))
Discount Rate = 6.39% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.24%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈224.0m ; Y1≈147.0m ; Y5≈67.1m
Fair Price DCF = N/A (negative equity: EV 2.14b - Net Debt 8.77b = -6.63b; debt exceeds intrinsic value)
EPS Correlation: -8.75 | EPS CAGR: -41.13% | SUE: 0.0 | # QB: 0
Revenue Correlation: 2.47 | Revenue CAGR: 4.47% | SUE: 0.03 | # QB: 0
EPS next Year (2026-12-31): EPS=8.91 | Chg30d=-0.855 | Revisions Net=+0 | Growth EPS=-47.0% | Growth Revenue=+4.0%